NasdaqGS:DXCMMedical Equipment
DexCom’s Q1 2026 Earnings Might Change The Case For Investing In DexCom (DXCM)
DexCom, the San Diego-based continuous glucose monitoring company, are set to release its fiscal first-quarter 2026 results on April 30, with consensus forecasts for diluted earnings coming in at US$0.47 per share, which analysts had expected to be 46.9% higher than the same quarter a year earlier.
This earnings release matters because...